check_circleStudy Completed

Bayer Identifier:
16411
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
SD/MD study in Chinese,BAY1192631, ICPP

Trial purpose

Key Participants Requirements

Sex

N/A

Age

N/A
  • -

  • -

Trial summary

Enrollment Goal
N/A
Trial Dates
June 2014 - August 2014
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Sivextro (Tedizolid phosphate, BAY119-2631)
Accepts Healthy Volunteer
N/A

Where to participate

StatusInstitutionLocation
Completed
Beijing, 100730, China

Trial design

Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.